title: Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis.
authors.affiliation: Rheumatology Department, St Vincent's Hospital, Melbourne, Victoria, Australia kbmorrisroe@gmail.com.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Morrisroe
authors.affiliation: Rheumatology Department, St Vincent's Hospital, Melbourne, Victoria, Australia.
authors.forename: Melinda
authors.initials: M
authors.lastname: Wong
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D002452:Cell Count; D004804:Eosinophils / Q000473:pathology; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000097:blood* / Q000139:chemically induced* / Q000175:diagnosis; D008875:Middle Aged; D019947:Receptors, Interleukin-6 / Q000276:immunology; D000069283:Rituximab / Q000627:therapeutic use; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; D000069283:Rituximab; C502936:tocilizumab